Thus, it is possible that the Fas/FasL pathway, rather than the NKG2D/NKG2D pathway, serves as an alternative mechanism for CIK cell cytotoxicity (with HSP90) in BL. The gene discussed is KLRK1; the disease is Burkitt lymphoma.